Established disease protocols including specific case definition, contact tracing, treatment and clinical management were closely followed during Kerala’s successful outbreak response.
After a Nipah virus outbreak in Kerala was contained in June 2018, the state and central government stopped monitoring fo the virus.
The Kerala Health Minister confirmed one case of Nipah virus infection in a 23-year-old from Ernakulam.
Nipah virus, a zoonotic disease transmitted to humans from several different animal species, infection gets its name from the village in Malaysia where the person from whom the virus was first isolated succumbed to the disease.
In a new study, remdesivir, an experimental antiviral drug, completely protected four African green monkeys from a lethal dose of Nipah virus,
Researchers studying the transmission of Nipah virus over 14 years of outbreak investigations in Bangladesh found that adult cases with respiratory symptoms transmitted the virus to more individuals than other cases.
There are no licensed drugs to counter Nipah virus infection. Researchers considered nine Nipah proteins as potential therapeutic targets and computationally identified putative peptides and small molecules inhibitors.
Researchers took advantage of a modified rabies virus vector, and incorporated a gene from Nipah virus - creating a viral particle that displays components of both viruses on its surface.
The Uniformed Services University of the Health Sciences (USU), along with Profectus Biosciences, Inc., the Vanderbilt University Medical Center, Mapp Biopharmaceutical, Inc., and the University of Texas Medical Branch (UTMB), have been awarded up to $24.5 million to advance treatments for the highly lethal henipaviruses, Nipah and Hendra.
The Tripura government on Tuesday, March 19, sounded an alert after the death of five members of a family from Nipah virus in a Bangladesh village bordering West Bengal.